Literature DB >> 30357564

Regulatory mechanisms of sclerostin expression during bone remodeling.

Masanori Koide1, Yasuhiro Kobayashi2.   

Abstract

Osteocytes are embedded in bone matrices and are connected to each other to respond to mechanical loading on bone. Recent studies have demonstrated the roles of mechanical loading in bone accrual. Bone responds to mechanical loading by decreasing the expression of sclerostin, an inhibitor of Wnt/β-catenin signals, in osteocytes. This increases bone mass because the activation of Wnt/β-catenin signals in bone microenvironments promotes bone formation and suppresses bone resorption. Thus, in recent years, sclerostin have attracted increasing attention in bone metabolism. However, the regulatory mechanism of sclerostin expression during bone remodeling has not been fully elucidated. In this review, we summarized the regulation of bone formation and resorption by Wnt signals, a Wnt/β-catenin signal inhibitor sclerostin, and molecular mechanisms by which the expression of sclerostin is suppressed by mechanical loading and parathyroid hormone. We also discuss a possibility that osteoclasts suppress the expression of sclerostin during bone remodeling, which in turn, promote bone formation. The effectiveness of an anti-sclerostin antibody with anti-dickkopf-1 antibody for increasing bone mass was discussed.

Entities:  

Keywords:  Bone remodeling; Osteoblasts; Osteoclasts; Osteocytes; Sclerostin

Mesh:

Substances:

Year:  2018        PMID: 30357564     DOI: 10.1007/s00774-018-0971-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  83 in total

1.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

2.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 3.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

Authors:  T Suda; N Takahashi; N Udagawa; E Jimi; M T Gillespie; T J Martin
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

4.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

5.  Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

Authors:  W Balemans; M Ebeling; N Patel; E Van Hul; P Olson; M Dioszegi; C Lacza; W Wuyts; J Van Den Ende; P Willems; A F Paes-Alves; S Hill; M Bueno; F J Ramos; P Tacconi; F G Dikkers; C Stratakis; K Lindpaintner; B Vickery; D Foernzler; W Van Hul
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

6.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

8.  Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.

Authors:  W Balemans; N Patel; M Ebeling; E Van Hul; W Wuyts; C Lacza; M Dioszegi; F G Dikkers; P Hildering; P J Willems; J B G M Verheij; K Lindpaintner; B Vickery; D Foernzler; W Van Hul
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

9.  Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling.

Authors:  Bingyu Mao; Wei Wu; Gary Davidson; Joachim Marhold; Mingfa Li; Bernard M Mechler; Hajo Delius; Dana Hoppe; Peter Stannek; Carmen Walter; Andrei Glinka; Christof Niehrs
Journal:  Nature       Date:  2002-05-26       Impact factor: 49.962

Review 10.  The Wnts.

Authors:  Jeffrey R Miller
Journal:  Genome Biol       Date:  2001-12-28       Impact factor: 13.583

View more
  14 in total

1.  Predisposing factors for a second fragile hip fracture in a population of 1130 patients with hip fractures, treated at Oulu University Hospital in 2013-2016: a retrospective study.

Authors:  Nelli Helynen; Lotta Rantanen; Petri Lehenkari; Maarit Valkealahti
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-15       Impact factor: 3.067

Review 2.  Mechanical stimuli-mediated modulation of bone cell function-implications for bone remodeling and angiogenesis.

Authors:  Wenqing Liang; Xudong Wu; Yongqiang Dong; Xuerong Chen; Ping Zhou; Fangming Xu
Journal:  Cell Tissue Res       Date:  2021-10-19       Impact factor: 5.249

Review 3.  Wnt signaling: a double-edged sword in protecting bone from cancer.

Authors:  Xun Sun; Kexin Li; Bai-Yan Li; Hiroki Yokota
Journal:  J Bone Miner Metab       Date:  2022-08-30       Impact factor: 2.976

Review 4.  Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis.

Authors:  Kridtapat Sirisereephap; Tomoki Maekawa; Hikaru Tamura; Takumi Hiyoshi; Hisanori Domon; Toshihito Isono; Yutaka Terao; Takeyasu Maeda; Koichi Tabeta
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 5.  Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.

Authors:  Ellen Otto; Paul-Richard Knapstein; Denise Jahn; Jessika Appelt; Karl-Heinz Frosch; Serafeim Tsitsilonis; Johannes Keller
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 6.  The Regulation of Bone Metabolism and Disorders by Wnt Signaling.

Authors:  Kazuhiro Maeda; Yasuhiro Kobayashi; Masanori Koide; Shunsuke Uehara; Masanori Okamoto; Akihiro Ishihara; Tomohiro Kayama; Mitsuru Saito; Keishi Marumo
Journal:  Int J Mol Sci       Date:  2019-11-06       Impact factor: 5.923

7.  Effects of fluid flow shear stress to mouse muscle cells on the bone actions of muscle cell-derived extracellular vesicless.

Authors:  Yoshimasa Takafuji; Kohei Tatsumi; Naoyuki Kawao; Kiyotaka Okada; Masafumi Muratani; Hiroshi Kaji
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

Review 8.  The Role of Sclerostin in Bone Diseases.

Authors:  Elias S Vasiliadis; Dimitrios-Stergios Evangelopoulos; Angelos Kaspiris; Ioannis S Benetos; Christos Vlachos; Spyros G Pneumaticos
Journal:  J Clin Med       Date:  2022-02-02       Impact factor: 4.241

Review 9.  Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders.

Authors:  Hongzhen Chen; Dewei Shang; Yuguan Wen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 10.  Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.

Authors:  Kazuhiro Maeda; Ken Yoshida; Tetsuro Nishizawa; Kazuhiro Otani; Yu Yamashita; Hinako Okabe; Yuka Hadano; Tomohiro Kayama; Daitaro Kurosaka; Mitsuru Saito
Journal:  Int J Mol Sci       Date:  2022-03-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.